Undifferentiated Ovarian Carcinoma Recruiting Phase 1 / 2 Trials for Sodium iodide (DB11119)

IndicationStatusPhase
DBCOND0028876 (Undifferentiated Ovarian Carcinoma)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02068794MV-NIS Infected Mesenchymal Stem Cells in Treating Patients With Recurrent Ovarian CancerTreatment